These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 36631980)

  • 1. The homeodomain of Oct4 is a dimeric binder of methylated CpG elements.
    Tan DS; Cheung SL; Gao Y; Weinbuch M; Hu H; Shi L; Ti SC; Hutchins AP; Cojocaru V; Jauch R
    Nucleic Acids Res; 2023 Feb; 51(3):1120-1138. PubMed ID: 36631980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing POU dimerization preferences converts Oct6 into a pluripotency inducer.
    Jerabek S; Ng CK; Wu G; Arauzo-Bravo MJ; Kim KP; Esch D; Malik V; Chen Y; Velychko S; MacCarthy CM; Yang X; Cojocaru V; Schöler HR; Jauch R
    EMBO Rep; 2017 Feb; 18(2):319-333. PubMed ID: 28007765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical POU domain residues confer Oct4 uniqueness in somatic cell reprogramming.
    Jin W; Wang L; Zhu F; Tan W; Lin W; Chen D; Sun Q; Xia Z
    Sci Rep; 2016 Feb; 6():20818. PubMed ID: 26877091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hierarchical Oct4 Binding in Concert with Primed Epigenetic Rearrangements during Somatic Cell Reprogramming.
    Chen J; Chen X; Li M; Liu X; Gao Y; Kou X; Zhao Y; Zheng W; Zhang X; Huo Y; Chen C; Wu Y; Wang H; Jiang C; Gao S
    Cell Rep; 2016 Feb; 14(6):1540-1554. PubMed ID: 26832419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Oct4 in maintaining and regaining stem cell pluripotency.
    Shi G; Jin Y
    Stem Cell Res Ther; 2010 Dec; 1(5):39. PubMed ID: 21156086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OCT4: dynamic DNA binding pioneers stem cell pluripotency.
    Jerabek S; Merino F; Schöler HR; Cojocaru V
    Biochim Biophys Acta; 2014 Mar; 1839(3):138-54. PubMed ID: 24145198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic epigenetic regulation of the Oct4 and Nanog regulatory regions during neural differentiation in rhesus nuclear transfer embryonic stem cells.
    Wang K; Chen Y; Chang EA; Knott JG; Cibelli JB
    Cloning Stem Cells; 2009 Dec; 11(4):483-96. PubMed ID: 20025521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A unique Oct4 interface is crucial for reprogramming to pluripotency.
    Esch D; Vahokoski J; Groves MR; Pogenberg V; Cojocaru V; Vom Bruch H; Han D; Drexler HC; Araúzo-Bravo MJ; Ng CK; Jauch R; Wilmanns M; Schöler HR
    Nat Cell Biol; 2013 Mar; 15(3):295-301. PubMed ID: 23376973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential recruitment of methylated CpG binding domains by the orphan receptor GCNF initiates the repression and silencing of Oct4 expression.
    Gu P; Le Menuet D; Chung AC; Cooney AJ
    Mol Cell Biol; 2006 Dec; 26(24):9471-83. PubMed ID: 17030610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
    Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
    Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanog, Oct4 and Tet1 interplay in establishing pluripotency.
    Olariu V; Lövkvist C; Sneppen K
    Sci Rep; 2016 May; 6():25438. PubMed ID: 27146218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pluripotency reprogramming by competent and incompetent POU factors uncovers temporal dependency for Oct4 and Sox2.
    Malik V; Glaser LV; Zimmer D; Velychko S; Weng M; Holzner M; Arend M; Chen Y; Srivastava Y; Veerapandian V; Shah Z; Esteban MA; Wang H; Chen J; Schöler HR; Hutchins AP; Meijsing SH; Pott S; Jauch R
    Nat Commun; 2019 Aug; 10(1):3477. PubMed ID: 31375664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of OCT4 Ubiquitination Increases OCT4 Protein Stability and ASH2L-B-Mediated H3K4 Methylation Promoting Pluripotency Acquisition.
    Li S; Xiao F; Zhang J; Sun X; Wang H; Zeng Y; Hu J; Tang F; Gu J; Zhao Y; Jin Y; Liao B
    Stem Cell Reports; 2018 Oct; 11(4):973-987. PubMed ID: 30269953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Oct4-activating compounds that enhance reprogramming efficiency.
    Li W; Tian E; Chen ZX; Sun G; Ye P; Yang S; Lu D; Xie J; Ho TV; Tsark WM; Wang C; Horne DA; Riggs AD; Yip ML; Shi Y
    Proc Natl Acad Sci U S A; 2012 Dec; 109(51):20853-8. PubMed ID: 23213213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional reprogramming and chromatin remodeling accompanies Oct4 and Nanog silencing in mouse trophoblast lineage.
    Carey TS; Choi I; Wilson CA; Floer M; Knott JG
    Stem Cells Dev; 2014 Feb; 23(3):219-29. PubMed ID: 24059348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Key features of the POU transcription factor Oct4 from an evolutionary perspective.
    Bakhmet EI; Tomilin AN
    Cell Mol Life Sci; 2021 Dec; 78(23):7339-7353. PubMed ID: 34698883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reprogramming towards pluripotency requires AID-dependent DNA demethylation.
    Bhutani N; Brady JJ; Damian M; Sacco A; Corbel SY; Blau HM
    Nature; 2010 Feb; 463(7284):1042-7. PubMed ID: 20027182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NKX3-1 is required for induced pluripotent stem cell reprogramming and can replace OCT4 in mouse and human iPSC induction.
    Mai T; Markov GJ; Brady JJ; Palla A; Zeng H; Sebastiano V; Blau HM
    Nat Cell Biol; 2018 Aug; 20(8):900-908. PubMed ID: 30013107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromatin states of core pluripotency-associated genes in pluripotent, multipotent and differentiated cells.
    Barrand S; Collas P
    Biochem Biophys Res Commun; 2010 Jan; 391(1):762-7. PubMed ID: 19944068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reptin regulates pluripotency of embryonic stem cells and somatic cell reprogramming through Oct4-dependent mechanism.
    Do EK; Cheon HC; Jang IH; Choi EJ; Heo SC; Kang KT; Bae KH; Cho YS; Seo JK; Yoon JH; Lee TG; Kim JH
    Stem Cells; 2014 Dec; 32(12):3126-36. PubMed ID: 25185564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.